Association between metabolic syndrome, diabetes mellitus, inflammation and cognitive dysfunctions in schizophrenia: a cross-sectional analysis
Alexander Kancsev, Marie Anne Engh, András Attila Horváth, Péter Hegyi, Oguz Kelemen, Szabolcs Kéri · 2025
Read Association between metabolic syndrome, diabetes mellitus, inflammation and cognitive dysfunctions in schizophrenia: a cross-sectional analysis by Alexander Kancsev, Marie Anne Engh, András Attila Horváth, Péter Hegyi, Oguz Kelemen, Szabolcs Kéri (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12708724.txt.
Description
Kancsev and co-authors compare thinking skills and inflammation across schizophrenia patients with and without metabolic disease. Metabolic syndrome and diabetes are common in this illness and may deepen cognitive harm. Their 2025 study examines 218 adults in three groups: schizophrenia alone, with metabolic syndrome, or with diabetes, using a standard thinking battery and two blood inflammation markers.
The diabetes group scored lowest on attention and delayed memory, while other skills did not differ. One marker, IL-6, climbed stepwise across the three groups; the other did not differ. Across everyone, higher IL-6 and blood sugar tracked with weaker attention and delayed memory. The authors caution that a one time snapshot cannot prove cause, and call for longer studies with wider marker panels.
Catalog record
| CREATOR | Alexander Kancsev, Marie Anne Engh, András Attila Horváth, Péter Hegyi, Oguz Kelemen, Szabolcs Kéri |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |